← Back to Search

Genetic Testing for Prostate Cancer

N/A

Waitlist Available

Led By Hala Borno, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline and exit/follow-up visit (up to 2 days)

Awards & highlights

Study Summary

This trial looks at whether providing culturally relevant genetic testing education to African American men with prostate cancer, by a community-based health coach, can help improve their knowledge, attitudes, and awareness of genetic testing.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline and exit/follow-up visit (up to 2 days)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline and exit/follow-up visit (up to 2 days)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and exit/follow-up visit (up to 2 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Consent rate for germline testing

Secondary outcome measures

Decisional conflict scale score

Other outcome measures

Highly penetrant germline genetic mutation rate and variants of unknown significance among all participants who undergo germline testing

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Cohort B (educational session, survey, genetic testing)Experimental Treatment3 Interventions

Patients participate in educational session with health coach over 60 minutes. Patients also complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Patients may undergo genetic testing.

Group II: Cohort A (survey, genetic testing)Active Control2 Interventions

Patients complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Patients may also undergo genetic testing.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lazarex Cancer FoundationUNKNOWN

1 Previous Clinical Trials

252 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,514 Previous Clinical Trials

15,244,409 Total Patients Enrolled

51 Trials studying Prostate Cancer

17,023 Patients Enrolled for Prostate Cancer

Hala Borno, MDPrincipal InvestigatorUniversity of California, San Francisco

2 Previous Clinical Trials

302 Total Patients Enrolled

1 Trials studying Prostate Cancer

50 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts ongoing for this experiment?

"Data from clinicaltrials.gov reveals this trial is actively enrolling participants, with its initial posting on January 15th 2021 and most recent update occurring February 22nd 2022."

Answered by AI

What is the estimated size of this clinical investigation?

"Affirmative. Information on clinicaltrials.gov demonstrates that this study, which was originally posted January 15th 2021, is actively seeking volunteers. Fifty participants need to be enrolled from one site of the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer

2021. "Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04763980.